Shopping Cart
Remove All
Your shopping cart is currently empty
VK-1727
😃Good
Catalog No. T78598
Alias VK1727
VK-1727, a selective small molecule inhibitor of EBNA1, reduces the DNA binding activity of EBNA1 while simultaneously restricting the proliferation and metabolic activity of EBV-positive cells, it does so without influencing the viability of EBV-negative cells, thereby demonstrating specificity. VK-1727 is primarily employed in researchs that focus on multiple sclerosis, in which it serves as a tool compound to interrogate EBNA1-mediated mechanisms in disease-related processes.
VK-1727
😃Good
Purity: 98.074%
Catalog No. T78598Alias VK1727
VK-1727, a selective small molecule inhibitor of EBNA1, reduces the DNA binding activity of EBNA1 while simultaneously restricting the proliferation and metabolic activity of EBV-positive cells, it does so without influencing the viability of EBV-negative cells, thereby demonstrating specificity. VK-1727 is primarily employed in researchs that focus on multiple sclerosis, in which it serves as a tool compound to interrogate EBNA1-mediated mechanisms in disease-related processes.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $297 | - | In Stock | |
| 5 mg | $745 | - | In Stock | |
| 10 mg | $1,180 | - | In Stock | |
| 25 mg | $1,780 | - | In Stock | |
| 50 mg | $2,380 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:98.074%
Contact us for more batch information
Product Introduction
Bioactivity
Chemical Properties
| Description | VK-1727, a selective small molecule inhibitor of EBNA1, reduces the DNA binding activity of EBNA1 while simultaneously restricting the proliferation and metabolic activity of EBV-positive cells, it does so without influencing the viability of EBV-negative cells, thereby demonstrating specificity. VK-1727 is primarily employed in researchs that focus on multiple sclerosis, in which it serves as a tool compound to interrogate EBNA1-mediated mechanisms in disease-related processes. |
| In vitro | Methods: EBV+ cells were treated with VK-1727 (25 μM, 72 hours), and the cell cycle was analyzed by flow cytometry. Results: VK-1727 significantly reduced the total number of G2-phase cells in EBV+ cells (HC1-2, SMS1-3, and AMS1-4), while no similar effect was observed in EBV− cells. [1] |
| Synonyms | VK1727 |
| Molecular Weight | 451.51 |
| Formula | C29H25NO4 |
| Smiles | COC(C1=CC=CC(C#CC(C=C2)=CC=C2OC3CCOCC3)=C1C4=CC=C(C=CN5)C5=C4)=O |
| Color | Yellow |
| Appearance | Solid |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (177.18 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (7.31 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy VK-1727 | purchase VK-1727 | VK-1727 cost | order VK-1727 | VK-1727 chemical structure | VK-1727 in vitro | VK-1727 formula | VK-1727 molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.